Efficacy and safety of highly purified menotropin versus recombinant follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection cycles: a randomized, comparative trial-Reference-Cited by-同舟云学术

Efficacy and safety of highly purified menotropin versus recombinant follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection cycles: a randomized, comparative trial

Published:2002-09 Issue:3 Volume:78 Page:520-528
ISSN:0015-0282
Container-title:Fertility and Sterility
language:en
Short-container-title:Fertility and Sterility

Author:

Funder

Ferring Pharmaceuticals

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Reproductive Medicine

Reference24 articles.

1. Effects of profound suppression of luteinizing hormone during ovarian stimulation on follicular activity, oocytes and embryo function in cycles stimulated with purified follicle stimulating hormone;Fleming;Hum Reprod,1998

2. Results of ovarian induction using human menopausal gonadotrophin or purified follicle-stimulating hormone in hypogonadotrophic hypogonadism patients;Shoham;Fertil Steril,1991

3. Follicle stimulating hormone versus human menopausal gonadotrophins for in vitro fertilization;Daya;Fertil Steril,1995

4. Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction;Westergaard;Hum Reprod,2000

5. Implications of using follicle-stimulating hormone preparations depleted of luteinizing hormone to achieve follicular growth in in vitro fertilization;Agrawal;Gynecol Endocrinol,1998

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analytical Investigation of the Profile of Human Chorionic Gonadotropin in Highly Purified Human Menopausal Gonadotrophin Preparations;International Journal of Molecular Sciences;2024-08-29

2. Competence of Combined Low Dose of Human Chorionic Gonadotropin (HCG) and Clomiphene Citrate (CC) Versus Continued CC during Ovulation Induction in Women with CC-Resistant Polycystic Ovarian Syndrome: A Randomized Controlled Trial;Medicina;2024-08-12

3. Highly Purified Human Menopausal Gonadotropin (HP-hMG) Versus Recombinant Follicle-Stimulating Hormone (rFSH) for Controlled Ovarian Stimulation in US Predicted High-Responder Patients: A Cost-Comparison Analysis;PharmacoEconomics - Open;2023-07-22

4. The therapeutic effects of rFSH versus uFSH/uHMG on ovarian stimulation in women undergoing assisted reproductive technology: a meta-analysis of randomized controlled trials;Archives of Gynecology and Obstetrics;2023-07-20

5. Follicle-Stimulating Hormone Biological Products: Does Potency Predict Clinical Efficacy?;International Journal of Molecular Sciences;2023-05-19